{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:29:11Z","timestamp":1789907351346,"version":"4.0.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T00:00:00Z","timestamp":1414627200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0110918","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T18:11:49Z","timestamp":1414692709000},"page":"e110918","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Formulation of the Microbicide INP0341 for In Vivo Protection against a Vaginal Challenge by Chlamydia trachomatis"],"prefix":"10.1371","volume":"9","author":[{"given":"Christian","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoly","family":"Slepenkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara B. E.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas H.","family":"Fagerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel A. S.","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellena M.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,10,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijantimicag.2012.05.023","article-title":"In vitro anti-HIV-1 activity of salicylidene acylhydrazide compounds","volume":"40","author":"DN Forthal","year":"2012","journal-title":"Int J Antimicrob Ag"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1128\/IAI.73.5.3104-3114.2005","article-title":"Small-molecule inhibitors specifically targeting type III secretion","volume":"73","author":"R Nordfelth","year":"2005","journal-title":"Infect Immun"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijantimicag.2010.03.018","article-title":"Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseria gonorrhoeae","volume":"36","author":"H Chu","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/IAI.00023-07","article-title":"Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron","volume":"75","author":"A Slepenkin","year":"2007","journal-title":"Infect Immun"},{"key":"ref5","unstructured":"Chu H, Slepenkin A, Elofsson M, Keyser P, Peterson EM (2010) Characterization of the inhibition of HSV-2 in vitro by INPs, a class of salicylidene acylhydrazide compounds; 2010; San Diego, California. 141."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/infdis\/jir552","article-title":"Protection of Mice From a Chlamydia trachomatis Vaginal Infection Using a Salicylidene Acylhydrazide, a Potential Microbicide","volume":"204","author":"A Slepenkin","year":"2011","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1115\/1.2206198","article-title":"Squeezing Flows of Vaginal Gel Formulations Relevant to Microbicide Drug Delivery","volume":"128","author":"SL Kieweg","year":"2006","journal-title":"J Biomech Eng"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e48328","DOI":"10.1371\/journal.pone.0048328","article-title":"Is Wetter Better? An Evaluation of Over-the-Counter Personal Lubricants for Safety and Anti-HIV-1 Activity","volume":"7","author":"CS Dezzutti","year":"2012","journal-title":"PLoS ONE"},{"key":"ref9","unstructured":"Garg S, Tambwekar KR, Vermani K, Garg A, Kaul CL, <etal>et al<\/etal>.. (2001) Compendium of Pharmaceutical Excipients for Vaginal Formulations. Pharm Technol Drug Deliv. 14\u201324."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00007435-200107000-00010","article-title":"Tests of BufferGel for Contraception and Prevention of Sexually Transmitted Diseases in Animal Models","volume":"28","author":"L Zeitlin","year":"2001","journal-title":"Sex Transm Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1016\/S0264-410X(99)00131-0","article-title":"Intranasal immunization with Chlamydia trachomatis, serovar E, protects from a subsequent vaginal challenge with the homologous serovar","volume":"17","author":"EM Peterson","year":"1999","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1530\/jrf.0.1010287","article-title":"Induction of infertility by the Chlamydia trachomatis mouse pneumonitis biovar in strains of mice that differ in their response to the 60 kDa heat shock protein","volume":"101","author":"A Khamesipour","year":"1994","journal-title":"J Reprod Fertil"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1128\/IAI.56.4.885-891.1988","article-title":"Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity","volume":"56","author":"EM Peterson","year":"1988","journal-title":"Infect Immun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.bmc.2010.02.022","article-title":"Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia","volume":"18","author":"MK Dahlgren","year":"2010","journal-title":"Bioorgan Med Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1023\/A:1014224900524","article-title":"Experimental and Computational Screening Models for Prediction of Aqueous Drug Solubility","volume":"19","author":"CS Bergstr\u00f6m","year":"2002","journal-title":"Pharm Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"DH Owen","year":"1999","journal-title":"Contraception"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/AAC.01368-10","article-title":"Vaginal Microbicide Gel for Delivery of IQP-0528, a Pyrimidinedione Analog with a Dual Mechanism of Action against HIV-1","volume":"55","author":"A Mahalingam","year":"2011","journal-title":"Antimicrob Agents Ch"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-7824(00)00184-0","article-title":"Rheological properties of contraceptive gels","volume":"62","author":"DH Owen","year":"2000","journal-title":"Contraception"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.polymdegradstab.2009.04.020","article-title":"Oxidative and photooxidative degradation of poly(acrylic acid)","volume":"94","author":"NB Shukla","year":"2009","journal-title":"Polym Degrad Stabil"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/jps.20118","article-title":"Surfactant-mediated dissolution: Contributions of solubility enhancement and relatively low micelle diffusivity","volume":"93","author":"A Balakrishnan","year":"2004","journal-title":"J Pharm Sci"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Holmberg K, J\u00f6nsson B, Kronberg B, Lindman B (2003) Surfactants and polymers in aqueous solution. Chichester: John Wiley &amp; Sons Ltd.","DOI":"10.1002\/0470856424"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(02)11079-8","article-title":"Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial","volume":"360","author":"L Van Damme","year":"2002","journal-title":"Lancet"},{"key":"ref23","unstructured":"Evans EB, Priston R, Willoughby JAS, Wagner HN, McKim JMJ (2012) Assessment of an <italic>In Vitro<\/italic> Human Vaginal Epithelial Model for Predicting Vaginal Irritation. Society of Toxicolog\u00fds 52nd Annual Meeting San Francisco, Abstract 1816."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejpb.2008.09.028","article-title":"Mucoadhesive polymeric platforms for controlled drug delivery","volume":"71","author":"GP Andrews","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/QAD.0b013e32834541d9","article-title":"Safety and effectiveness of BufferGel and 0.5% PRO 2000 gel for the prevention of HIV infection in women","volume":"25","author":"SS Abdool Karim","year":"2011","journal-title":"AIDS"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0110918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T08:23:11Z","timestamp":1598430191000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0110918"}},"subtitle":[],"editor":[{"given":"David M.","family":"Ojcius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,30]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0110918","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,30]]}}}